These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31436479)

  • 1. A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication Nonadherence.
    Davis-Ajami ML; Pakyz A; Wu J; Baernholdt M
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1409-1419. PubMed ID: 31436479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.
    Gatwood JD; Chisholm-Burns M; Davis R; Thomas F; Potukuchi P; Hung A; Kovesdy CP
    J Manag Care Spec Pharm; 2018 Apr; 24(4):379-389. PubMed ID: 29578849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P; Heller DA; Peterson AM
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venue of receiving diabetes self-management education and training and its impact on oral diabetic medication adherence.
    Wu J; Davis-Ajami ML; Noxon V; Lu ZK
    Prim Care Diabetes; 2017 Apr; 11(2):162-170. PubMed ID: 27840086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
    Davis-Ajami ML; Fink JC; Wu J
    J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Patient-Centered Medical Homes on Quality of Care and Medication Adherence in Patients with Diabetes Mellitus.
    An J
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1272-1284. PubMed ID: 27783547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors.
    Rascati KL; Worley K; Meah Y; Everhart D
    J Manag Care Spec Pharm; 2017 Mar; 23(3):299-306. PubMed ID: 28230454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does increased adherence to medications change health care financial burdens for adults with diabetes?
    Miller GE; Sarpong EM; Hill SC
    J Diabetes; 2015 Nov; 7(6):872-80. PubMed ID: 25817601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Supplemental Nutrition Assistance Program Participation and Cost-Related Medication Nonadherence Among Older Adults With Diabetes.
    Pooler JA; Srinivasan M
    JAMA Intern Med; 2019 Jan; 179(1):63-70. PubMed ID: 30453334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R; Rajagopalan R; Camacho FT; Huston SA; Murray FT; Anderson RT
    Clin Ther; 2003 Nov; 25(11):2958-71. PubMed ID: 14693318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.
    Kirkman MS; Rowan-Martin MT; Levin R; Fonseca VA; Schmittdiel JA; Herman WH; Aubert RE
    Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of use and expenses associated with mail-service pharmacy in adults with diabetes.
    Wu J; Davis-Ajami ML; Noxon V
    J Am Pharm Assoc (2003); 2015; 55(1):41-51. PubMed ID: 25539092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Dashputre AA; Gatwood KS; Gatwood J
    J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.